Xilio Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
XLO
CUSIP
98422T100
Type
Equity
Class
COM
Num filings
36
Total reported value, excl. options
$24.7 M
Manager Report Date Value ($000) Shares Option Type